| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |